Logo 1 Logo 2

Clinical Trial Details

Trial ID: L1117
Source ID: NCT00032435
Associated Drug: Pal-40 Active
Title: Homocysteine Study (HOST)
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: End Stage Renal Disease|Renal Failure
Interventions: DRUG: PAL-40 Active|DRUG: PAL-40 Placebo
Outcome Measures:
Sponsor/Collaborators: Sponsor: US Department of Veterans Affairs | Collaborators: Pan American Laboratories|Abbott Diagnostics Division
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 2003
Study Type: INTERVENTIONAL
Study Designs: Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose:
Start Date: 2001-05
Completion Date: 2006-09
Results First Posted:
Last Update Posted: 2010-10-15
Locations: VA Medical Center, Birmingham, Birmingham, Alabama, 35233, United States|Health Economics Resource Center (HERC), Menlo Park, Menlo Park, California, 94025, United States|VA Palo Alto Health Care System, Palo Alto, California, 94304-1290, United States|VA San Diego Healthcare System, San Diego, San Diego, California, 92161, United States|VA Eastern Colorado Health Care System, Denver, Denver, Colorado, 80220, United States|VA Connecticut Health Care System (West Haven), West Haven, Connecticut, 06516, United States|VA Medical Center, DC, Washington, District of Columbia, 20422, United States|VA Medical Center, Bay Pines, Bay Pines, Florida, 33708, United States|North Florida/South Georgia Veterans Health System, Gainesville, Florida, 32608, United States|VA Medical Center, Miami, Miami, Florida, 33125, United States|West Palm Beach VA Medical Center, West Palm Beach, Florida, 33410, United States|Edward Hines, Jr. VA Hospital, Hines, Illinois, 60141-5000, United States|Richard Roudebush VA Medical Center, Indianapolis, Indianapolis, Indiana, 46202-2884, United States|Southeast Veterans Healthcare System, New Orleans, New Orleans, Louisiana, 70112, United States|VA Medical Center, Jamaica Plain Campus, Boston, Massachusetts, 02130, United States|VA Ann Arbor Healthcare System, Ann Arbor, Michigan, 48113, United States|John D. Dingell VA Medical Center, Detroit, Detroit, Michigan, 48201, United States|VA Medical Center, Minneapolis, Minneapolis, Minnesota, 55417, United States|G.V. (Sonny) Montgomery VA Medical Center, Jackson, Jackson, Mississippi, 39216, United States|VA Medical Center, Kansas City MO, Kansas City, Missouri, 64128, United States|VA Medical Center, Bronx, Bronx, New York, 10468, United States|VA Western New York Healthcare System at Buffalo, Buffalo, New York, 14215, United States|New York Harbor HCS, New York, New York, 10010, United States|VA Medical Center, Northport, Northport, New York, 11768, United States|VA Medical Center, Syracuse, Syracuse, New York, 13210, United States|VA Medical Center, Cleveland, Cleveland, Ohio, 44106, United States|VA Medical Center, Dayton, Dayton, Ohio, 45428, United States|VA Medical Center, Portland, Portland, Oregon, 97201, United States|VA Pittsburgh Health Care System, Pittsburgh, Pennsylvania, 15240, United States|Ralph H Johnson VA Medical Center, Charleston, Charleston, South Carolina, 29401-5799, United States|VA Medical Center, Memphis, Memphis, Tennessee, 38104, United States|VA North Texas Health Care System, Dallas, Dallas, Texas, 75216, United States|Michael E. DeBakey VA Medical Center (152), Houston, Texas, 77030, United States|Hunter Holmes McGuire VA Medical Center, Richmond, Virginia, 23249, United States|VA Puget Sound Health Care System, Seattle, Seattle, Washington, 98108, United States|Zablocki VA Medical Center, Milwaukee, Milwaukee, Wisconsin, 53295-1000, United States|VA Medical Center, San Juan, San Juan, 00921, Puerto Rico
URL: https://clinicaltrials.gov/show/NCT00032435

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress